An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age

Trial Profile

An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Hepatitis A vaccine; MMR-varicella zoster virus vaccine
  • Indications Chickenpox; Hepatitis A; Measles; Mumps; Rubella
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 18 Nov 2008 Secondary trial identifier 'V251-066' found and added according to ClinicalTrials.gov.
    • 18 Nov 2008 Last checked against ClinicalTrials.gov record.
    • 18 Nov 2008 Actual patient number identified as 1800 from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top